Mechanisms of miR-3189-3p-mediated inhibition of c-MYC translation in triple negative breast cancer

被引：0
|
作者：
Cecilia Vittori
Duane Jeansonne
Hassan Yousefi
Celeste Faia
Zhen Lin
Krzysztof Reiss
Francesca Peruzzi
机构：
[1] Louisiana State University Health Sciences Center and Stanley S. Scott Cancer Center,Department of Biochemistry
[2] Louisiana State University Health Sciences Center,Department of Pathology and Laboratory Medicine
[3] Tulane University Health Sciences Center and Tulane Cancer Center,undefined
来源：
Cancer Cell International | / 22卷
关键词：
4EBP1; miR-3189-3p; Translation; c-MYC; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] SAE2 Expression in c-MYC Positive Triple-Negative Breast Carcinomas
    Lally, Kimberly
    Fan, Xuemo
    Alkan, Serhan
    MODERN PATHOLOGY, 2016, 29 : 52A - 53A
  • [22] SAE2 Expression in c-MYC Positive Triple-Negative Breast Carcinomas
    Lally, Kimberly
    Fan, Xuemo
    Alkan, Serhan
    LABORATORY INVESTIGATION, 2016, 96 : 52A - 53A
  • [23] Role of Harmaline in Inhibiting c-Myc, Altering Molecular Typing, and Promoting Apoptosis in Triple-Negative Breast Cancer
    Xu, Haoyi
    Ma, Yan
    Li, Huiling
    Song, Xinyu
    Liu, Yuanjing
    Mierzhakenmu, Zuliyaer
    Yan, Kang
    Xu, Rui
    Zhao, Ziqian
    Yuan, Hongyi
    Dong, Chao
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 855 - 866
  • [24] Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway
    Yang, Lihui
    Li, Jiachen
    Li, Yongzhuo
    Zhou, Yongli
    Wang, Ziqian
    Zhang, Dahao
    Liu, Jinlu
    Zhang, Xiaodong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)
  • [25] Nanoconjugate mediated inhibition of EGFR expression of triple negative breast cancer
    Inoue, Satoshi
    Patil, Rameshwar
    Portilla, Jose
    Ding, Hui
    Konda, Bindu
    Espinoza, Andres
    Phillips, H. Westley
    Elramsisy, Adam
    Holler, Eggehard
    Black, Keith L.
    Ljubimova, Julia
    CANCER RESEARCH, 2011, 71
  • [26] Fatty acid inhibition reduces MYC expression in triple-negative breast cancer
    Sritharan, N.
    Lee, J.
    Goga, A.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S108 - S108
  • [27] INHIBITION OF C-MYC EXPRESSION BY PHOSPHOROTHIOATE ANTISENSE OLIGONUCLEOTIDE IDENTIFIES A CRITICAL ROLE FOR C-MYC IN THE GROWTH OF HUMAN BREAST-CANCER
    WATSON, PH
    PON, RT
    SHIU, RPC
    CANCER RESEARCH, 1991, 51 (15) : 3996 - 4000
  • [28] MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer
    Yang, Aimin
    Qin, Shenghui
    Schulte, Bradley A.
    Ethier, Stephen P.
    Tew, Kenneth D.
    Wang, Gavin Y.
    CANCER RESEARCH, 2017, 77 (23) : 6641 - 6650
  • [29] c-Myc and Frizzled 8 play a major role in the regulation of cancer stem cells and drug resistance in triple-negative breast cancer
    Yin, Shuping
    Cheriyan, Vino T.
    Rishi, Arun K.
    Reddy, Kaladhar B.
    CANCER RESEARCH, 2015, 75
  • [30] miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
    Martini, Silvia
    Zuco, Valentina
    Tortoreto, Monica
    Percio, Stefano
    Campi, Elisa
    El Bezawy, Rihan
    Doldi, Valentina
    Landesman, Yosef
    Pennati, Marzia
    Zaffaroni, Nadia
    PHARMACEUTICALS, 2021, 14 (06)
12345